Search Page

1

Cite

Share

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.

Bowling EA, Wang JH, Gong F, Wu W, Neill NJ, Kim IS, Tyagi S, Orellana M, Kurley SJ, Dominguez-Vidaña R, Chung HC, Hsu TY, Dubrulle J, Saltzman AB, Li H, Meena JK, Canlas GM, Chamakuri S, Singh S, Simon LM, Olson CM, Dobrolecki LE, Lewis MT, Zhang B, Golding I, Rosen JM, Young DW, Malovannaya A, Stossi F, Miles G, Ellis MJ, Yu L, Buonamici S, Lin CY, Karlin KL, Zhang XH, Westbrook TF. Bowling EA, et al. Among authors: yu l. Cell. 2021 Jan 21;184(2):384-403.e21. doi: 10.1016/j.cell.2020.12.031. Epub 2021 Jan 14. Cell. 2021. PMID: 33450205

Cite

Share

2

Cite

Share

Antiviral treatment in COVID-19: which is the most promising?-a narrative review.

Yadav AK, Wen S, Xu X, Yu L. Yadav AK, et al. Among authors: yu l. Ann Palliat Med. 2021 Jan;10(1):707-720. doi: 10.21037/apm-20-1755. Epub 2021 Jan 11. Ann Palliat Med. 2021. PMID: 33440983 Free article. Review.

Cite

Share

3

Cite

Share

Netrin-1 and its receptor DCC modulate survival and death of dopamine neurons and Parkinson's disease features.

Jasmin M, Ahn EH, Voutilainen MH, Fombonne J, Guix C, Viljakainen T, Kang SS, Yu LY, Saarma M, Mehlen P, Ye K. Jasmin M, et al. Among authors: yu ly. EMBO J. 2021 Feb 1;40(3):e105537. doi: 10.15252/embj.2020105537. Epub 2020 Dec 22. EMBO J. 2021. PMID: 33351190 Free PMC article.

Cite

Share

4

Cite

Share

Chemoreactive Nanotherapeutics by Metal Peroxide Based Nanomedicine.

Hu H, Yu L, Qian X, Chen Y, Chen B, Li Y. Hu H, et al. Among authors: yu l. Adv Sci (Weinh). 2020 Dec 3;8(1):2000494. doi: 10.1002/advs.202000494. eCollection 2020 Jan. Adv Sci (Weinh). 2020. PMID: 33437566 Free PMC article. Review.

Cite

Share

5

Cite

Share

Hyperprogressive disease in patients receiving immune checkpoint inhibitors.

Zhang H, Fang X, Li D, Yang M, Yu L, Ding Y, Shen H, Yuan Y. Zhang H, et al. Among authors: yu l. Curr Probl Cancer. 2021 Jun;45(3):100688. doi: 10.1016/j.currproblcancer.2020.100688. Epub 2020 Dec 9. Curr Probl Cancer. 2021. PMID: 33334611 Review.

Cite

Share

6

Cite

Share

Current strategies for managing intestinal failure-associated liver disease.

Secor JD, Yu L, Tsikis S, Fligor S, Puder M, Gura KM. Secor JD, et al. Among authors: yu l. Expert Opin Drug Saf. 2021 Mar;20(3):307-320. doi: 10.1080/14740338.2021.1867099. Epub 2020 Dec 30. Expert Opin Drug Saf. 2021. PMID: 33356650 Review.

Cite

Share

7

Cite

Share

Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p.

Yu L, Sui B, Fan W, Lei L, Zhou L, Yang L, Diao Y, Zhang Y, Li Z, Liu J, Hao X. Yu L, et al. J Extracell Vesicles. 2021 Jan;10(3):e12056. doi: 10.1002/jev2.12056. Epub 2021 Jan 18. J Extracell Vesicles. 2021. PMID: 33489015 Free PMC article.

Cite

Share

8

Cite

Share

Ethical guidance for geriatric clinical research in China.

Yu L, Li X, Zhang P, Zhang G. Yu L, et al. Aging Med (Milton). 2020 Dec 21;3(4):218-223. doi: 10.1002/agm2.12138. eCollection 2020 Dec. Aging Med (Milton). 2020. PMID: 33392425 Free PMC article.

Cite

Share

9

Cite

Share

Protein adsorption to poly(2-aminoethyl methacrylate)-grafted Sepharose gel: Effects of chain length and charge density.

Yu L, Li C, Liu Y, Sun Y. Yu L, et al. J Chromatogr A. 2021 Feb 8;1638:461869. doi: 10.1016/j.chroma.2020.461869. Epub 2020 Dec 31. J Chromatogr A. 2021. PMID: 33433375

Cite

Share

10

Cite

Share

Protocol for generation of lung adenocarcinoma organoids from clinical samples.

Li Z, Yu L, Chen D, Meng Z, Chen W, Huang W. Li Z, et al. Among authors: yu l. STAR Protoc. 2020 Dec 28;2(1):100239. doi: 10.1016/j.xpro.2020.100239. eCollection 2021 Mar 19. STAR Protoc. 2020. PMID: 33426535 Free PMC article.

Cite

Share